Chevilly Larue, France

Reda Agnaou

This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: L'oreal. Active years: 2024-2026.


% Patents Active = 75.0

 

Average Co-Inventor Count = 2.8

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Reda Agnaou: Innovator in Cosmetic Compositions

Introduction

Reda Agnaou is a notable inventor based in Chevilly Larue, France. He has made significant contributions to the field of cosmetic compositions, holding a total of 4 patents. His work focuses on innovative formulations that enhance the effectiveness and safety of cosmetic products.

Latest Patents

Among his latest patents, Reda Agnaou has developed a range of cleansing compositions that utilize non-modified clay and polyglycerol surfactants. Additionally, he has created a cosmetic composition that includes at least one clay, one crystallizable fatty compound, and one liposoluble UV filter. These inventions highlight his commitment to advancing cosmetic science through effective and safe formulations.

Career Highlights

Reda Agnaou is currently employed at L'Oréal, a leading global cosmetics company. His role at L'Oréal allows him to leverage his expertise in cosmetic formulations, contributing to the development of innovative products that meet consumer needs.

Collaborations

Throughout his career, Reda has collaborated with talented professionals, including Catherine Marion and Franck Clement. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking cosmetic solutions.

Conclusion

Reda Agnaou's contributions to the field of cosmetic compositions demonstrate his innovative spirit and dedication to enhancing beauty products. His work continues to influence the industry, paving the way for future advancements in cosmetic science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…